APA (7th ed.) Citation

Murakami, S., Yamagishi, K., Kitani, A., Ueta, T., Matsuura, Y., Kubota, T., & Uezono, Y. (2026). Gefapixant Citrate, a Selective P2X3 Receptor Antagonist, May Improve Cancer-Related Hypergeusia: A Case Report. Journal of Palliative Medicine, 29(4), 557. https://doi.org/10.1177/10966218251385732

Chicago Style (17th ed.) Citation

Murakami, Satoshi, Kazutaka Yamagishi, Akira Kitani, Toru Ueta, Yasuaki Matsuura, Toru Kubota, and Yasuhito Uezono. "Gefapixant Citrate, a Selective P2X3 Receptor Antagonist, May Improve Cancer-Related Hypergeusia: A Case Report." Journal of Palliative Medicine 29, no. 4 (2026): 557. https://doi.org/10.1177/10966218251385732.

MLA (9th ed.) Citation

Murakami, Satoshi, et al. "Gefapixant Citrate, a Selective P2X3 Receptor Antagonist, May Improve Cancer-Related Hypergeusia: A Case Report." Journal of Palliative Medicine, vol. 29, no. 4, 2026, p. 557, https://doi.org/10.1177/10966218251385732.